cablivi kit
sanofi-aventis canada inc - caplacizumab - kit - 11mg - caplacizumab 11mg - antithrombotic agents, misc.
tysabri solution
biogen canada inc - natalizumab - solution - 300mg - natalizumab 300mg - immunomodulatory agents
zinbryta solution
biogen canada inc - daclizumab beta - solution - 150mg - daclizumab beta 150mg - immunomodulatory agents
zinbryta solution
biogen canada inc - daclizumab beta - solution - 150mg - daclizumab beta 150mg - immunomodulatory agents
mvasi solution
amgen canada inc - bevacizumab - solution - 25mg - bevacizumab 25mg - antineoplastic agents
mvasi solution
amgen canada inc - bevacizumab - solution - 25mg - bevacizumab 25mg - antineoplastic agents
bambevi solution
apotex inc - bevacizumab - solution - 100mg - bevacizumab 100mg - antineoplastic agents
bambevi solution
apotex inc - bevacizumab - solution - 400mg - bevacizumab 400mg - antineoplastic agents
abevmy solution
biosimilar collaborations ireland limited - bevacizumab - solution - 400mg - bevacizumab 400mg - antineoplastic agents
abevmy solution
biosimilar collaborations ireland limited - bevacizumab - solution - 100mg - bevacizumab 100mg - antineoplastic agents